Latest Leadership News

Patronus Resources reports a robust $70 million in cash and investments alongside 2.3 million ounces of gold equivalent resources, underpinning a multi-commodity growth strategy across Western Australia and the Northern Territory.

Pacific Edge reports a 9% decline in Cxbladder test volumes amid Medicare coverage loss but gains momentum with new clinical validation and a CMS pricing boost.

The Supreme Court of New South Wales has approved the scheme for Pacific Equity Partners to acquire Johns Lyng Group, setting the stage for a significant ownership change and trading suspension on the ASX.

Resonance Health reveals a robust growth strategy targeting $17 million revenue by FY26, powered by AI-enhanced medical imaging and global clinical trial services expansion.

Latrobe Magnesium has locked in $10 million through a placement and entitlement offer to complete its demonstration plant and push towards commercial-scale magnesium production.

Dicker Data has acknowledged the suspension of former CEO David Dicker following a confidential whistleblower complaint but maintains the event did not materially affect the company’s securities or leadership structure.

Cryosite Limited reports a strong start to FY26 with a 22% revenue increase and a strategic warehouse acquisition that doubles capacity, positioning the company for sustained growth in clinical trial logistics.

INOVIQ Limited has raised $11.5 million through a $9.5 million placement and a $2 million share purchase plan to accelerate the development and commercialisation of its EXO-OC ovarian cancer test and exosome therapeutic program.

Energy Resources of Australia reported a $47.1 million cash outflow from operations and a $75.4 million investment spend in the September quarter, reducing cash reserves to $108.3 million.

ClearVue Technologies has raised A$4.6 million in a strongly supported placement to accelerate international certification and ongoing innovation of its solar façade products.

Ainsworth Game Technology announces the immediate resignation of CEO Harald Neumann and appoints COO Ryan Comstock as acting CEO while searching for a permanent replacement.

PainChek Limited has secured its first US customer, Jewish Home Family, just days after receiving FDA De Novo clearance for its AI-powered pain assessment app, marking a significant step into the $100 million US aged care market.